Loading...
Persistent bone marrow depression following short-term treatment with temozolomide
Temozolomide (TMZ) is, in combination with radiotherapy (RT), the treatment of choice for glioblastoma multiforme. Although generally well tolerated, haematological side effects are observed in approximately 1–10% of patients receiving TMZ. We report a case of a patient who developed severe bone mar...
Na minha lista:
| Udgivet i: | BMJ Case Rep |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMJ Publishing Group
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4854153/ https://ncbi.nlm.nih.gov/pubmed/27130558 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2016-215797 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|